{
    "2021-08-20": [
        [
            {
                "time": "",
                "original_text": "交银国际：白云山维持中性评级 目标价升至23.30港元",
                "features": {
                    "keywords": [
                        "交银国际",
                        "白云山",
                        "中性评级",
                        "目标价",
                        "23.30港元"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【券商聚焦】交银微升白云山(00874)目标价3.6%至23.3港元 维持“中性”评级",
                "features": {
                    "keywords": [
                        "券商",
                        "交银",
                        "白云山",
                        "目标价",
                        "3.6%",
                        "23.3港元",
                        "中性评级"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "广药白云山上半年现金流大增",
                "features": {
                    "keywords": [
                        "广药",
                        "白云山",
                        "上半年",
                        "现金流",
                        "大增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}